0000930413-12-000226.txt : 20120119 0000930413-12-000226.hdr.sgml : 20120119 20120119184419 ACCESSION NUMBER: 0000930413-12-000226 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120117 FILED AS OF DATE: 20120119 DATE AS OF CHANGE: 20120119 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stancic Ana CENTRAL INDEX KEY: 0001320271 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-12957 FILM NUMBER: 12535560 MAIL ADDRESS: STREET 1: CHAMPIONS BIOTECHNOLOGY, INC. STREET 2: 855 NORTH WOLFE STREET, SUITE 619 CITY: BALTIMORE STATE: MD ZIP: 21205 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ENZON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000727510 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 222372868 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 20 KINGSBRIDGE ROAD STREET 2: ATT: GENERAL COUNSEL CITY: PISCATAWAY STATE: NJ ZIP: 08854 BUSINESS PHONE: 732-980-4500 MAIL ADDRESS: STREET 1: 20 KINGSBRIDGE ROAD STREET 2: ATT: GENERAL COUNSEL CITY: PISCATAWAY STATE: NJ ZIP: 08854 FORMER COMPANY: FORMER CONFORMED NAME: ENZON PHARMACEUTICALS INC DATE OF NAME CHANGE: 20021211 FORMER COMPANY: FORMER CONFORMED NAME: ENZON PHARMACEUTICAL INC DATE OF NAME CHANGE: 20021210 FORMER COMPANY: FORMER CONFORMED NAME: ENZON INC DATE OF NAME CHANGE: 19920703 4 1 c68177_4.xml OWNERSHIP DOCUMENT X0304 4 2012-01-17 0 0000727510 ENZON PHARMACEUTICALS INC ENZN 0001320271 Stancic Ana C/O ENZON PHARMACEUTICALS, INC. 20 KINGSBRIDGE ROAD PISCATAWAY NJ 08854 0 1 0 0 Executive VP, COO, PEO, CFO Common Stock 2012-01-17 4 D 0 45000 0 D 15000 D Common Stock 2012-01-17 4 A 0 45000 0 A 70000 D Restricted Stock Units ("RSUs") granted by the Issuer pursuant to its 2011 Stock Option and Incentive Plan and qualified under Rule 16b-3(d). Each unit represents a contingent right to receive one share of the Issuer's Common Stock. The two reported transactions involved an amendment of an outstanding RSU grant, resulting in the deemed cancellation of the "old" RSUs and the making of a replacement RSU grant. The RSU grant was originally made on November 17, 2011, and provided that the RSUs would vest in full on November 17, 2014, if the Reporting Person remained employed by the Issuer on such date; provided, however, that the vesting of 50% of the RSUs was to be accelerated upon the Reporting Person's achievement of certain performance milestones determined by the Board of Directors of the Issuer. On January 17, 2012, the RSU grant was amended to provide that the RSUs will vest in three (3) tranches. Of the 45,000 RSUs granted, 15,000 RSUs will vest on each of November 17, 2012, November 17, 2013 and November 17, 2014, in each case if the Reporting Person remains employed by the Issuer on such date. /s/ Andrew Rackear, Attorney-in-Fact 2012-01-19